PTC Therapeutics, Inc. (PTCT)
71.47
-1.25
(-1.72%)
USD |
NASDAQ |
May 15, 16:00
71.41
-0.06
(-0.08%)
After-Hours: 20:00
PTC Therapeutics Shareholders Equity (Quarterly) : -180.46M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.505B |
| Keros Therapeutics, Inc. | 285.63M |
| Insmed, Inc. | 704.85M |
| Madrigal Pharmaceuticals, Inc. | 543.45M |
| Protagonist Therapeutics, Inc. | 655.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.869B |
| Total Liabilities (Quarterly) | 3.050B |
| Debt to Equity Ratio | -2.189 |
| Current Ratio | 2.440 |
| Net Debt Paydown Yield | -0.02% |